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O xytocin (OT) is a nine amino acid neuropeptide produced in the supraoptic and paraventricular nuclei of the hypothalamus that is secreted directly into the brain and via the posterior pituitary gland to the peripheral circulation. Although long recognized for its role in female reproduction, more recent evidence indicates that OT regulates a range of physiologic processes in both genders, including eating behavior and metabolism (1) .
Animal studies have shown that OT is a potent regulator of caloric intake and metabolism . Low levels of OT mRNA in the hypothalamus of severely obese Sim1 haploinsufficient mice were associated with excessive food intake and weight gain, which were both reversed with OT administration (24) . Consistent with these results, centrally or peripherally administered OT led to reduced food intake, increased energy expenditure, and weight loss in diet-induced obese rodents and primates (3-6, 15, 17, 21, 23, 25, 26) . In rodents, food intake increased plasma OT levels with a peak at 10 minutes after a meal associated with subsequent attenuation of feeding (27) .
Studies of men have reported a reduction in caloric intake after a single intranasal dose of OT, with preferential effects in reducing the consumption of palatable foods (28) (29) (30) (31) . Interestingly, other than one study reporting reduced satiety after an OT infusion (32) , exogenous OT did not affect subjective appetite in men (28, 29, 33) . There are few data examining the response of endogenous OT to food intake and the relation between OT and appetite. Reported results are conflicting, with no change in plasma OT observed after a large meal containing high fiber and fat (34) or a liquid test meal (35) , and an increase in OT levels after a fat-rich liquid meal of 300 mL of corn oil (36) in healthy individuals. To our knowledge the detailed evaluation of postprandial OT levels after a standardized meal with a balanced proportion of macronutrient content in healthy humans is lacking. Additionally, most studies published in humans included a small number of subjects, primarily males, leaving unanswered the question of whether OT impacts subjective appetite in females. This is of particular interest, because gender differences in OT system functions have been consistently reported (37, 38) .
In our study, we aimed to determine the endogenous OT response to food intake and its relationship to subjective satiety and hunger across a wide age range of healthy females. Whereas some data suggest age-related differences in OT, information is limited, particularly in humans (39, 40) . We therefore examined the relationship between age and OT levels in this cohort, hypothesizing based on preclinical studies that OT levels would decrease with age. Because estradiol is known to increase OT levels and it has been consistently reported that food intake and appetite can change across the menstrual cycle (41, 42) , we also examined whether OT levels after food ingestion differed by menstrual phase. Based on known positive associations of estradiol with OT levels, we hypothesized that OT levels would be lower during the early to midfollicular phase of the menstrual cycle, when estradiol levels are overall lower than in other phases.
Subjects and Methods
We enrolled 55 normal-weight females, 10 to 45 years old. All study participants were recruited from the community through advertisements and referrals from health care providers. Outpatient study visits took place at the Translational and Clinical Research Center at Massachusetts General Hospital or the Massachusetts General Hospital Athinoula A. Martinos Center for Biomedical Imaging. Subjects were excluded for any unstable medical illness including cardiovascular, hepatic, renal, respiratory, endocrine, psychiatric, and neurologic diseases. Subjects with a prior history of gastrointestinal tract surgery (including gastrectomy, gastric bypass surgery, and small or large bowel resection), use of drugs affecting metabolism or appetite (e.g. lorcaserin, phentermine, topiramate, glucagonlike peptide-1 agonists, metformin), untreated hypothyroidism, or hematocrit ,30.0% were excluded. Active substance abuse, use of systemic hormones (oral/transdermal contraceptive) within 8 weeks or medroxyprogesterone acetate within three months prior to the visit, and pregnancy or breastfeeding were also exclusion criteria, as was excessive exercise within the last three months (having run .25 miles in any one week or having exercised .10 hours in any one week).
The study was approved by the Institutional Review Board of Partners HealthCare. Informed consent was obtained from subjects at least 18 years old and parents of subjects younger than 18 years (n = 10). Informed assent was obtained from subjects younger than 18 years. In a subset of 12 females, participant characteristics and extracted OT levels have been previously reported (43, 44) .
A screening visit was conducted by a member of the medical team to determine eligibility for the protocol. After informed consent/assent, a complete medical history; physical examination, including height and weight; and blood and urine collection (serum or urine human chorionic gonadotropin, blood for hematocrit, and TSH) were performed in all subjects. In cases in which the family could provide records of the laboratory work required for eligibility performed within two months of the screening visit, these laboratories were not repeated, except for urine human chorionic gonadotropin testing. Participants were considered to be in the early to midfollicular phase if the main study visit was performed between day 1 and 10 of the menstrual cycle. The five premenarcheal subjects were included in the early to midfollicular phase group based on their low estrogen status. Results did not differ when the premenarcheal females were excluded from analysis. Percentage ideal body weight (%IBW) was calculated for all subjects, body mass index (BMI, kg/m 2 )was calculated for subjects $20 years and BMI z-score was calculated for subjects ,20 years.
Qualifying participants returned for a main study visit and were asked to fast overnight prior to the morning blood draw. A mixed meal standardized for macronutrient content (;20% protein, 20% fat, 60% carbohydrate) of ;400 kcal was given to all participants. A mixed meal of 400 kcal has previously been shown to induce endocrine and brain circuitry responses in humans (43, 45) . Participants were asked to eat the entire meal over 15 minutes. Quantification of nutrient intake was performed by a dietician. Quantity of food consumed was calculated as total kilocalories consumed per body weight (kcal/kg). Subjective appetite was assessed immediately prior and immediately after the meal using Visual Analog Scales, a reliable and widely used method to assess subjective appetite (46) . Subjects were asked to answer questions about appetite by making a mark on a 10-cm line with extremes on either end indicating how they felt at that moment. For example, in response to the question, "How hungry are you?", the subject marked their degree of current hunger between the two extremes, "I am not hungry at all" on the left and "I have never been more hungry" on the right. Total scores were calculated by measuring the distance from the left side of the line in centimeters, resulting in scores ranging from 0 to 10. An intravenous catheter was placed and blood sampling for OT was performed fasting immediately before the meal and 30, 60, and 120 minutes after the start of the meal.
Biochemical measurements
Serum samples were stored at 280°C. Samples from all study subjects were run in a single batch. OT concentration was measured in unextracted serum by ELISA in the Brigham Research Assay Core Laboratory using reagents purchased from Enzo Life Sciences, Farmingdale, NY. We have previously demonstrated a robust correlation between extracted and unextracted serum OT levels (47) . The assay had a detection limit of 15 pg/mL. In-house quality control samples had a mean of 81 and 120 pg/mL, and a low-and high-quality control pools between-assay coefficient of variation of 18% and 20%, respectively. The cross-reactivity of Lys8-vasopressin, Arg8-vasopressin, met-enkephalin, vasoactive intestinal polypeptide, somatostatin, Ser4, Ile8-OT, and a-atrial natriuretic polypeptide in the OT assay is ,0.02%. As an integrated measure of postprandial changes in OT levels, OT area under the curve (AUC) was calculated using the trapezoidal formula with respect to the y-axis, including fasting OT levels and all the time points after the meal, as reported by Pruessner et al. (48) . Other biochemical measurements were obtained using standard techniques.
Statistical analysis
Nonnormally distributed variables were logarithmically transformed when possible to approximate a normal distribution. Spearman rank test was used to investigate correlations between OT levels and ratings of hunger and fullness. Comparisons of hormone levels at different timepoints were made using the two-sided paired t test. We used repeated measures ANOVA with the within-subject factor time (0, 30, 60, and 120 minutes) and between-subject factors menstrual cycle status (early to midfollicular phase vs other menstrual cycle phase) and age groups (,20 years and $20 years) to determine the effects of menstrual cycle and age on postprandial OT levels. Multivariate linear regression analyses were constructed to (i) determine the effect of menstrual cycle and age on postprandial OT levels after controlling for age and (ii) assess the relation between ratings of subjective appetite and OT parameters after controlling for confounders (kilocalories consumed/body weight, age, and menstrual cycle status). Statistical significance was defined as a two-tailed P value , 0.05. Data are reported as mean 6 SEM. Stata software V.14.2 (StataCorp LP, College Station, TX) was used for statistical analysis.
Results

Clinical characteristics of the participants
Clinical characteristics of the subjects are summarized in Table 1 . Mean age was 20.5 6 0.7 years and mean % IBW was 103.8 6 1.5%. Pubertal status of the five premenarcheal participants was assessed by physical examination. Tanner stages for breast development were 4 in one participant, 3 in two participants, 2 in one participant, and 1 in one participant. Tanner stages for pubic hair development were 3 in two participants, 2 in two participants and 1 in one participant. None of the participants were taking hormonal contraception or taking any medications other than multivitamin supplements (four individuals) or stable doses of levothyroxine (two individuals) for primary hypothyroidism (with normal TSH levels).
OT levels in response to mixed meal
On average participants consumed 391 6 6 kcal (94.3% 6 0.1%) of the mean 414-kcal standardized meal provided, composed of 17.8% 6 0.2% protein, 21.9% 6 0.5% fat and 60.3% 6 0.5% carbohydrates. Data are reported as mean 6 SEM.
Abbreviations: T0, time 0 minutes; T30, time 30 minutes; T60, time 60 minutes; T120, time 120 minutes; AUC, area under the curve a P = 0.001 (compared with baseline OT).
b P = 0.003 (compared with baseline OT). Fig. 1(a)] . The lowest OT level in each subject at any of the three timepoints after the meal was considered to be the OT nadir; mean nadir OT levels were 802.0 6 43.8 pg/mL. Mean percentage change in OT from baseline to nadir was 219.6% 6 3.0%. OT levels decreased after the meal in 47 subjects (85% of the participants) [ Fig. 1(b) ]. Only one subject had a substantial increase in OT from baseline to nadir (+58%); this outlier did not differ in age, BMI, Visual Analog Scales measurements, or food consumed from the average. Nadir OT levels were observed at 30 minutes after the meal in 18 (38%) participants, at 60 minutes in 21 (45%) participants, and at 120 minutes in 8 (17%) participants.
Effects of menstrual phase and age on OT levels and appetite
Mean OT levels in participants in the early to midfollicular phase of the menstrual cycle were significantly lower compared with those who were in other menstrual cycle phases, both while fasting and at all other timepoints after the meal [ Figs. 2(a) and 2(b) ]. There was no difference in the percent change of OT from baseline to nadir based on menstrual cycle status (Table 2) . We (a) OT AUC is lower in subjects in the early to midfollicular phase vs those in other menstrual cycle phases; and mean OT levels differed significantly across (b) menstrual cycle phase and (c) age groups at each time point (*P , 0.05). However, the overall postprandial OT profile was similar, regardless of the phase of the menstrual cycle (ANOVA: interaction of time*menstrual cycle phase was not significant) and age group (ANOVA: interaction of time*age group was not significant).
applied repeated measures ANOVA to assess differences in overall OT levels (at all timepoints) according to menstrual cycle status: OT levels differed between females in the early to midfollicular phase and those in other menstrual cycle phases with lower OT levels in females tested in their early to midfollicular phase compared with females tested in other phases of their menstrual cycle (factor group: F 1,212 = 41.35, P , 0.001, ƞp 2 = 0.1632 and factor time: F 3,212 = 1.5, P = 0.217, ƞp 2 = 0.0207); but the interaction of time-menstrual cycle status was not significant (F 3,212 = 0.11, P = 0.953, ƞp 2 = 0.0015), indicating that females in the early to midfollicular phase did not differ from those in other menstrual cycle phases for their postprandial OT profile (i.e., the pattern of OT levels in response to the meal) [ Fig.  2(b) ]. Importantly, results after excluding five premenarcheal participants did not differ (data not shown). OT levels were inversely correlated with age at all timepoints (r s = 20.350 to 20.401, P # 0.009). Median age of study subjects was 20 years; younger participants (,20 years) had higher fasting and AUC OT levels than older subjects ($20 years) (fasting: 1168.0 6 76.1 vs 880.5 6 63.5 pg/mL, P = 0.005 and AUC OT: 130,872 6 7523 vs 96,820 6 7189 pg/mL, P = 0.002) ( Table 2 ). Repeatedmeasures ANOVA was used to assess differences in overall OT levels (at all timepoints) according to age groups: OT levels differed between younger and older females with higher OT levels in younger than older women (factor group: F 1,212 = 35.11, P , 0.0001, ƞp 2 = 0.1421 and factor time: . Importantly, the effects of menstrual cycle status on OT AUC remained significant after controlling for age (early to midfollicular phase: b = 233027, P = 0.005; age: b = 22237, P = 0.035). Altogether menstrual cycle status and age explained 26.1% of OT AUC variation (R 2 = 0.261). No significant differences in subjective appetite postmeal were observed according to menstrual cycle status or age groups, after controlling for food consumed at the mixed meal (kcal/kg).
Relation between OT levels and subjective appetite
Whereas premeal subjective appetite measures were not associated with OT levels, postmeal ratings of hunger and fullness were related to the percent OT change from baseline to nadir (r s = 20.291, P = 0.03 and r s = 0.345, P = 0.009, respectively), indicating that the greater the decrease of OT after the meal, the higher the ratings of hunger and the lower the ratings of fullness after the meal (Fig. 3) . These findings persisted after excluding an outlier from the analysis (hunger: r s = 2-0.331, P = 0.014; fullness: r s = 0.372, P = 0.005). In multivariate regression analyses, these relations remained significant after controlling for food consumed at the mixed meal (kcal/kg), age, and menstrual cycle status (P = 0.023 for hunger and P = 0.0001 for fullness).
Discussion
To improve our understanding of OT physiology after food intake in healthy females, we examined the response of endogenous OT to food ingestion in relation to menstrual cycle phase and age; and the relationship between OT levels and subjective appetite. We demonstrate that (i) peripheral OT levels decrease after a mixed meal standardized for macro-nutrient content; (ii) OT levels are lower in the early to midfollicular phase of the menstrual cycle than in other phases of menstrual cycle; (iii) OT levels are higher in younger than older females; and (iv) postprandial decreases in OT levels are related to subjective appetite, with attenuated OT excursions associated with less hunger and a greater sense of fullness. These relationships between OT levels and appetite remained significant after controlling for quantity of food consumed, menstrual cycle status, and age. In addition, the postprandial OT pattern across the timepoints evaluated was not modified by menstrual cycle phase or age. To our knowledge, this is the first study to determine the endogenous OT secretion pattern in a large group of healthy females after a standardized mixed meal after controlling for menstrual status and age, two factors known to impact serum OT levels. Our findings suggest that the change in endogenous OT levels after a mixed meal, rather than the absolute values of OT may modulate subjective appetite. Prior studies in primarily rodent and nonhuman primate models have demonstrated that exogenous OT administration reduces food intake (3-5, 8-10, 12-18, 20, 21, 23, 25) and caloric consumption increases endogenous peripheral OT levels, with variable timing of the postprandial peak across species studied, namely rats (27) , dogs, or sows (49) . Interestingly, in rodents, peripheral OT secretion increases after gastric distention or administration of cholecystokinin-8, a meal-related satiety signal, two factors well-known to reduce food intake (27, 50) . In contrast, in our study of adolescent and adult human females, we found that serum OT levels decreased after a standardized mixed meal. Previous reports of OT secretory patterns after food intake in humans are conflicting. Two studies did not find any change in OT levels after a high-calorie meal (34) or liquid test meal (35) and another reported an increase in OT levels after a high-fat meal (36) . These differences may be explained by small sample size or differences in the content and quantity of meals consumed across studies. One study included a high-fat and high-fiber meal (mean of 2200 kcal consumed) (34), another used a liquid test meal (,200 kcal) (35) , and a third a high-fat liquid meal (300 mL of corn oil) (36), making comparisons across studies difficult. In our investigation, we used a standardized mixed meal and observed a substantial and consistent decrease in OT levels after food ingestion. Two prior investigations assessed the effects of a meal with a similar proportion of macronutrient content to the current study in healthy individuals and reported no changes in OT levels (35, 43) . However, the lack of effects demonstrated in those studies could be explained by small sample size, and in Stock et al. (35) the use of a liquid test meal and low caloric content (,200 kcal). Different assays and methodologies used to measure OT across studies could also partially explain these differences.
One potential explanation of why peripheral OT levels do not increase after food intake in humans is that peripheral OT levels may not reflect central OT functioning, namely the regulation of OT release within the brain can be independent of or differentially related to secretion into the blood (51, 52) . Whereas magnocellular OT neurons project to the posterior pituitary and ultimately secrete OT into the systemic circulation, parvocellular neurons and the somatodendrites of magnocellular OT neurons are responsible for central OT release into numerous brain regions (53) . An example of a dissociated pattern of OT release from dendrites and axon terminals has been reported after central administration of anorexigenic a-melanocyte-stimulating hormone, which leads to increased cFos expression in hypothalamic OT neurons, indicating activation, but a decrease in OT peripheral release via the posterior pituitary (51) . Similarly, after food ingestion, central and peripheral OT release patterns might differ in humans; reduced OT in the blood may reflect increased OT activity in appetite-regulating neurocircuitry. Alternatively, changes in peripheral OT levels may have direct effects on appetite. Peripheral sites of OT action including the gastrointestinal tract and vagus nerve have been implicated in the modulation of food intake (1). Consistent with this, the administration of a peripheral OT receptor antagonist in rats reduced the anorectic response to peripheral OT administration (11) .
Another possibility is that a larger amount of food intake and/or gastric distension elicited in response to food intake are necessary to induce an increase in peripheral OT levels. However, in a small group of subjects in another study, an increase in OT levels was not observed after a high-fat, high-calorie meal with an average consumption of 2200 kcal (27) .
There are few available data regarding endogenous OT secretion and satiety and hunger in humans. Available studies have evaluated subjective appetite measures after exogenous OT administration IV infusion or intranasal). Although one study reported that OT administration reduced satiety independent of volume intake (32), most studies did not find any impact of OT administration on subjective appetite measures in males (28, 29, 33 ). In the current study, we evaluated the effects of endogenous OT after a meal on subjective appetite measures in a large group of healthy females. Whereas fasting OT levels were not associated with subjective measures of appetite, we observed that the less pronounced the decrease of OT after a meal, the lower the ratings of hunger and the higher the ratings of fullness. Similar associations were observed between relative changes in subjective hunger (before and after the meal) and percent change in OT levels from fasting to nadir, i.e., the less pronounced the decrease of OT after the meal, the greater the reduction in hunger (data not shown). Importantly, the associations between percent change in OT and postprandial appetite remained significant after controlling for factors that may impact OT secretion, namely menstrual cycle status, age, and quantity of food consumed (39, 54) . Altogether these data suggest that the relative change in OT levels after a meal, but not the absolute values, are associated with postprandial ratings of hunger and fullness.
Plasma OT levels increase in physiological or pharmacological conditions related to increased estrogen exposure, such as pregnancy, the ovulatory phase of the menstrual cycle, or oral contraceptive treatment (54) (55) (56) . In our study, we observed lower mean fasting and postprandial OT levels in females in the early to midfollicular phase of their cycles, when estradiol levels are expected to be lower than in the late follicular, ovulatory, or luteal phase. However, the pattern of peripheral OT levels after food intake, including a postprandial decrease in OT levels, was similar between those in the early to midfollicular phase and other menstrual cycle phases. We thus demonstrate, that whereas menstrual cycle phase affects absolute OT values, it does not modify the pattern of postprandial OT secretion.
Interestingly, OT levels were higher in younger compared with older participants. However, age did not impact the postprandial OT profile; the older and younger groups had a similar pattern of OT reduction after food intake. Most of the extant data in OT and aging research has focused largely on animal models with limited applicability to humans. Information available in humans is scarce and results are mixed (39, 40) . Studies in nonhuman species suggest age-related differences in OT, providing substantial evidence for age-related decreases in oxytocinergic activity (39, 57, 58) . However, whether aging is accompanied by an increase or decrease in central and peripheral release of OT in humans is still under debate (59) . Whereas a reduced number of oxytocinergic cells in the paraventricular nuclei of elderly subjects postmortem was found in one study (60) , another did not report any difference (61) compared with younger adults. Our findings support the concept that as in other endocrine pathways, OT system dynamics and functions may change with age (62) . However, more studies in larger populations with broader age ranges and in males are necessary to confirm these findings.
In summary, contrary to findings in animal models, peripheral OT levels decrease after food intake in human females. However, consistent with the known anorexigenic effect of OT, the extent of postprandial OT reduction is associated with subjective measures of appetite, independent of menstrual cycle phase, age and amount of food intake. These data suggest that endogenous peripheral OT may play a role in the physiology of perceived hunger and satiety after food intake. Further studies are necessary to differentiate between the effects of central vs peripheral OT on sensations of hunger and satiety, as well as regulation of food intake. 
